No Data
No Data
We're Keeping An Eye On Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate
TD Cowen Keeps Their Buy Rating on Tenaya Therapeutics (TNYA)
Canaccord Genuity Adjusts Tenaya Therapeutics Price Target to $16 From $18, Maintains Buy Rating
Tenaya Therapeutics (TNYA) has an average rating of buy and price targets ranging from $7 to $40, according to analysts polled by Capital IQ. Price: 4.26, Change: +0.01, Percent Change: +0.24
Tenaya Therapeutics Is Maintained at Buy by Canaccord Genuity
Tenaya Therapeutics Is Maintained at Buy by Canaccord Genuity
Buy Rating Affirmed for Tenaya Therapeutics Amidst Promising Gene Therapy Advances
Maintaining a Buy Rating for Tenaya Therapeutics: A Comprehensive Financial and Pipeline Progress Analysis
No Data